hit counter

major depression

Analyzing Serum Biomarkers to Predict Antidepressant Efficacy in Depression (2023 Study)

by

Depression, a complex and often debilitating mental health condition, affects millions globally. Despite advances in psychiatric medicine, finding the right treatment remains a challenge for many. A recent comprehensive study, however, is shedding light on this issue by examining the role of serum biomarkers in predicting the effectiveness of antidepressant therapy. Highlights: Innovative Approach: This …

Read more

Non-Directive Supportive Therapy (NDST) for Major Depression: Is It Effective? (2024 Review)

by

Depression, a common yet complex mental health disorder, has various treatment options, including psychotherapies like Non-Directive Supportive Therapy (NDST). A recent meta-analysis sheds light on the effectiveness of NDST in treating depression, comparing it with control conditions and other therapies. Highlights: NDST has been identified as a moderately effective treatment for depression compared to control …

Read more

Can Lifestyle Factors Modify Risk of Psychiatric Disorders? (2024 Study)

by

Psychiatric disorders have increasingly become a significant public health concern, affecting a growing number of people globally. A study in focus utilized MR (Mendelian randomization), a method that leverages genetic data to explore causal relationships, to analyze the impact of 45 lifestyle factors on 13 psychiatric disorders. This extensive research involved GWAS summary statistics from …

Read more

Genetics & Depression: How Polygenic Risk Scores Predict Mood Over Long-Term (2024 Study)

by

A recent study examined how our genetic makeup influences our temperament traits, particularly in relation to depression. By analyzing the polygenic risk for depression (PRS) and its correlation with various temperament traits over time, this research provides significant insights into the complex interplay between genetics and mood. Highlights: High PRS Linked to Increased Persistence: Individuals …

Read more

Combo of Neuroimaging, Transcriptome, Epigenetics to Understand Gray Matter Abnormalities in Major Depression (2024 Study)

by

Major depressive disorder (MDD) affects millions worldwide, yet its underlying causes remain largely enigmatic. A new study integrated neuroimaging, transcriptomic, and epigenetic data to better understand the genetic underpinnings of MDD. This comprehensive approach revealed a complex interplay between brain structure, gene expression, and DNA methylation, offering new insights into this debilitating condition. Highlights: Integrative …

Read more

Biomarkers in Major Depression: Interleukin-33 (IL-33) & Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) (2024 Study)

by

Major depressive disorder (MDD) is a complex mental health condition that significantly impacts individuals’ lives globally. A recent study evaluates the biological underpinnings of this disorder, focusing on two specific biomarkers: interleukin-33 (IL-33) and mesencephalic astrocyte-derived neurotrophic factor (MANF). These findings could pave the way for new diagnostic and treatment strategies. Highlights: Major depressive disorder …

Read more

Comparison of Brexipiprazole vs. Aripiprazole for Treatment-Resistant Depression (2024 Study)

by

Antidepressant-resistant major depressive disorder (AR-MDD) poses significant challenges in psychiatric treatment. Antipsychotics like aripiprazole (ARI) and brexpiprazole (BRE) have emerged as effective adjunct therapies that may be more tolerable than older antipsychotics. Highlights: Both Brexipiprazole and Aripiprazole demonstrated better efficacy than placebo in treating AR-MDD in Japanese patients. Brexipiprazole showed a higher discontinuation rate due …

Read more